Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Description
Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial drug under development for treating acute bacterial skin and skin structure infections, as well as community-acquired pneumonia.